Simon Feys, Sam Vanmassenhove, Sirima Kraisin, Karen Yu, Cato Jacobs, Bram Boeckx, Seppe Cambier, Cristina Cunha, Yves Debaveye, Samuel M Gonçalves, Greet Hermans, Stephanie Humblet-Baron, Sander Jansen, Katrien Lagrou, Philippe Meersseman, Johan Neyts, Marijke Peetermans, Joana Rocha-Pereira, Rogier Schepers, Valérie Spalart, Marick R Starick, Karin Thevissen, Thomas Van Brussel, Tina Van Buyten, Pierre Van Mol, Christophe Vandenbriele, Lore Vanderbeke, Els Wauters, Alexander Wilmer, Johan Van Weyenbergh, Frank L Van De Veerdonk, Agostinho Carvalho, Paul Proost, Kimberly Martinod, Diether Lambrechts, Joost Wauters
BACKGROUND: COVID-19-associated pulmonary aspergillosis (CAPA) is a severe superinfection with the fungus Aspergillus affecting patients who are critically ill with COVID-19. The pathophysiology and the role of neutrophil extracellular traps (NETs) in this infection are largely unknown. We aimed to characterise the immune profile, with a focus on neutrophils and NET concentrations, of critically ill patients with COVID-19, with or without CAPA. METHODS: We conducted a single-centre, retrospective, observational study in two patient cohorts, both recruited at University Hospitals Leuven, Belgium...
January 19, 2024: The Lancet. Microbe